Long-Term Prognosis, Subsequent Pregnancy, Contraception and Overall Management of Peripartum Cardiomyopathy: Practical Guidance Paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy

Karen Sliwa(University of Cape Town), Johann Bauersachs(Medizinische Hochschule Hannover), Amam Mbakwem(University of Lagos), Alice M. Jackson(University of Glasgow), Denise Hilfiker‐Kleiner(Medizinische Hochschule Hannover), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Mark R. Johnson(Chelsea and Westminster Hospital NHS Foundation Trust), Peter van der Meer(University Medical Center Groningen), Mark C. Petrie(British Heart Foundation)
European Journal of Heart Failure
March 26, 2018
10.1002/ejhf.1178
Cited by 146

Related Papers

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
|European Heart Journal|2008|2.7k